09:49 | INDICES: ni Value, ni Growth, Défensif ! |  |
01/07 | DOJ Says J&J Talc Bankruptcy Violates Congressional Mass Tort Rules |  |
01/07 | Pharmaceutical companies still have the upper hand |  |
30/06 | FDA bittet Impfstoffhersteller um Anpassung auf Omikron-Sublinien |  |
30/06 | Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Talquetamab for.. |  |
30/06 | Hywin Holdings, FactSet Launch Global Health Care Index |  |
29/06 | NHIF, Janssen Kenya Sign MOU to Enhance Prostrate Cancer Drugs Access |  |
29/06 | Johnson & Johnson Unit Secures FDA's Breakthrough Therapy Designation For Talquetamab i.. |  |
29/06 | Estas empresas respetan el derecho al aborto en EE.UU. |  |
29/06 | Ces sociétés respectent le droit à l'avortement aux États-Unis |  |
28/06 | MeiraGTx Sees Positive Data From Phase 1/2 Trial of Botaretigene Sparoparvovec for X-Li.. |  |
27/06 | Janssen Receives Positive CHMP Opinion for IMBRUVICA (ibrutinib) in a Fixed-Duration Co.. |  |
24/06 | Johnson & Johnson's Janssen Receives EU Medicines Agency Panel's Backing for Leukemia D.. |  |
24/06 | J&J: avis favorable de l'UE pour un anti-leucémique |  |
24/06 | Johnson & Johnson's Unit Janssen Says EMA's Committee Backs Approval of Imbruvica to Tr.. |  |
24/06 | JOHNSON & JOHNSON'S JANSSEN: CHMP Backs Expanded Imbruvica Use in Chronic Lymphocytic Leu.. |  |
24/06 | J&J: confirme son engagement contre les maladies tropicales |  |
23/06 | JOHNSON & JOHNSON: Renews Commitment to Fight Neglected Tropical Diseases, Investing in B.. |  |
22/06 | Powell's tall order to reassure investors |  |
22/06 | ANALYST RECOMMENDATIONS: Johnson & Johnson, NatWest, Home Depot, Kraft Heinz, Vodafone... |  |
21/06 | Le roi des céréales Kellogg annonce sa scission en trois entreprises |  |
21/06 | TRANSCRIPT: Johnson & Johnson - Special Call |  |
21/06 | Johnson & Johnson Opens Asia-Pacific Satellite Center for Global Health Discovery in Si.. |  |
21/06 | Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Paci.. |  |
21/06 | Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Paci.. |  |
18/06 | AFRIQUE DU SUD: une "bataille difficile" remportée avec la levée des brevets |  |
17/06 | Standard & Poor's 500 Enters Bear Market Territory as Fed Pivot to Price Stability Fuel.. |  |
16/06 | Wall Street finit en forte baisse, craint que la Fed n'ait la main trop lourde |  |
16/06 | TRANSCRIPT: Johnson & Johnson Presents at Goldman Sachs 43rd Annual Global Healthcare Con.. |  |
16/06 | Federal Government Removes Vaccination Requirements For Domestic And Out-Bound Travel |  |
15/06 | Top Local Changemakers Addressing Health Equity Gaps Across the U.S. Named Johnson & Jo.. |  |
15/06 | Evotec enters a drug discovery collaboration with Janssen |  |
15/06 | JOHNSON & JOHNSON VISION ON TRACK FO: ACUVUE® OASYS MAX 1-Day |  |
15/06 | INSIDER SELL: Johnson & Johnson |  |
14/06 | Evotec, Johnson & Johnson's Unit Janssen Partner to Discover New Drug Candidates |  |
14/06 | Evotec kooperiert bei Wirkstoffforschung mit Janssen |  |
13/06 | Valneva risque de ne pas fournir son vaccin à l'Europe |  |
10/06 | Johnson & Johnson Unit Janssen Says Early Trial Data Shows Positive Results for Teclist.. |  |
10/06 | JOHNSON & JOHNSON: New IMBRUVICA® (ibrutinib) Data in Fixed-Duration Combination Regimen .. |  |
10/06 | JOHNSON & JOHNSON: Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bisp.. |  |
10/06 | Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results |  |
10/06 | Genmab Seeks $405 Million in New Arbitration With Janssen |  |
10/06 | Genmab Opens New Arbitration In Daratumumab License Dispute With Janssen |  |
08/06 | COVID-19 VACCINES: No Sharing Of Know-How |  |
08/06 | Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on .. |  |
08/06 | Janssen Presents Initial Results from the Phase 2 RAGNAR Study of BALVERSA (erdafitinib.. |  |
08/06 | Royal Philips - Willem Appelo to succeed Sophie Bechu as Philips Chief Operations Offic.. |  |
07/06 | Johnson & Johnson Unit Janssen Says Initial Data From Phase 2 Trial of Balversa Shows R.. |  |
07/06 | Philips Names Willem Appelo COO |  |
06/06 | Emergent Biosolutions Claims Janssen Pharmaceuticals Breached COVID-19 Vaccine Producti.. |  |
06/06 | SECTOR UPDATE: Health Care Stocks Slip Amid Losses for Biotechs |  |
06/06 | Emergent Biosolutions Claims Janssen Pharmaceuticals Breached COVID-19 Vaccine Producti.. |  |
06/06 | SECTOR UPDATE: Health Care Stocks Edging Higher This Afternoon |  |
06/06 | SECTOR UPDATE: Health Care |  |
06/06 | US Stocks Weakening in Midday Trading but Largely Staying on Positive Ground |  |
06/06 | Top Midday Gainers |  |
06/06 | Yumanity Therapeutics Shares Soar on Kineta Deal |  |
06/06 | J&J Risks Up to $420 Million Liability as Emergent Claims COVID-19 Jab Contract Breach |  |
06/06 | Wall Street Set for Gains, China Tech ADRs Rise on Signs of Easing Regulatory Pressure |  |
06/06 | J&J: résultats encourageants dans le myélome multiple |  |
06/06 | Emergent BioSolutions Says Janssen Has Breached Covid Vaccine Contract |  |
06/06 | The Janssen Pharmaceutical - Phase 3 SHINE Results Show IMBRUVICA (ibrutinib)-Based Com.. |  |
06/06 | The Janssen Pharmaceutical Companies - Longer-term Data from CARTITUDE-1 Study Demonstr.. |  |
06/06 | The Janssen Pharmaceutical Companies - Updated Data for Janssen's Bispecific Teclistama.. |  |
06/06 | Top Premarket Gainers |  |
06/06 | Yumanity to Sell Neurosciences Candidates, Merge With Kineta |  |
06/06 | J&J: données mises à jour sur le teclistamab |  |
06/06 | JOHNSON & JOHNSON: ETHICON LAUNCHES NEXT GENERATION ECHELON™ 3000 STAPLER DESIGNED .. |  |
06/06 | Johnson & Johnson agreed to acquire Assets of Wholesale Brokerage & Binding and Managin.. |  |
05/06 | JOHNSON & JOHNSON: Longer-term Data from CARTITUDE-1 Study Demonstrate Continued Deep and.. |  |
03/06 | Johnson & Johnson's Imbruvica Meets Target in Late-Stage Mantle Cell Lymphoma Trial in .. |  |
03/06 | JOHNSON & JOHNSON: Phase 3 SHINE Results Show IMBRUVICA® (ibrutinib)-Based Combination Re.. |  |
02/06 | Bristol Myers, J&J Arthritis Drugs Cut Covid-19 Deaths in NIH Study |  |
02/06 | The Janssen Pharmaceutical - New Data Show Patients Treated with First-in-Class TREMFYA.. |  |
01/06 | J&J: nouvelles données positives autour du Tremfya |  |